Chicago, IL, United States of America

Bo Shiun Lai

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bo Shiun Lai. Retrieved from https://idiyas.com/inventor/bo-shiun-lai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bo Shiun Lai: Innovator in Pharmaceutical Formulations

Introduction

Bo Shiun Lai is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of infections. His innovative work focuses on the development of advanced therapeutic formulations.

Latest Patents

Bo Shiun Lai holds a patent for "Conjugate constructs, delivery, and use for treatment of disease." This patent discloses pharmaceutical formulations of antisense peptide-conjugated phosphorodiamidate morpholino oligomers. The methods outlined in this patent are particularly directed towards the treatment of apicomplexan infections.

Career Highlights

Throughout his career, Bo Shiun Lai has demonstrated a commitment to advancing medical science through his inventions. His work has the potential to significantly impact the treatment of various infections, showcasing his dedication to improving healthcare outcomes.

Collaborations

Bo Shiun Lai has collaborated with esteemed colleagues, including Rima McLeod and William Witola. These partnerships have contributed to the development and refinement of his innovative pharmaceutical formulations.

Conclusion

Bo Shiun Lai is a distinguished inventor whose work in pharmaceutical formulations is paving the way for new treatments for infections. His contributions to the field are invaluable and highlight the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…